Difloxacin HCl: Applied Workflows in Antimicrobial and MDR R
2026-08-04
Difloxacin HCl stands apart as a quinolone antimicrobial antibiotic, uniquely enabling both robust antimicrobial susceptibility testing and innovative multidrug resistance (MDR) reversal assays. This article bridges advanced research use-cases, stepwise protocol enhancements, and troubleshooting strategies—all leveraging APExBIO’s high-purity Difloxacin HCl.
Amyloid Beta-peptide (25-35): Advanced Neuroinflammation Ins
2026-08-04
Explore Amyloid Beta-peptide (25-35) (human) as a versatile model for dissecting neuroinflammatory processes in Alzheimer’s disease research. This article offers a unique focus on its utility for microglial phenotype modulation and translational assay strategies.
PEDV Exploits IMPDH-Dependent Nucleotide Biosynthesis for Re
2026-08-03
This study reveals that porcine epidemic diarrhea virus (PEDV) reprograms host nucleotide metabolism, specifically hijacking IMPDH-dependent guanine biosynthesis, to facilitate its replication. Both genetic and pharmacological inhibition of IMPDH—using Merimepodib (VX-497)—markedly suppresses PEDV, highlighting IMPDH as a promising host-directed antiviral target.
Homoharringtonine: Cytotoxic Alkaloid Benchmarks in Cancer &
2026-08-03
Homoharringtonine is a cytotoxic alkaloid with defined activity against leukemic cells and SARS-CoV-2. Its mechanism—80S ribosome binding and protein synthesis inhibition—enables precise cell cycle arrest. This article details molecular rationale, evidence, and protocol integration for research applications.
Panobinostat (LBH589) and Apoptosis: New Insights for Cancer
2026-08-02
Explore how Panobinostat (LBH589) drives apoptosis in cancer cells through novel HDAC inhibition and links to recent discoveries on RNA Pol II-mediated cell death. This article offers a deeper, evidence-based perspective for advanced epigenetic and apoptosis research.
NP-40 Lysis Buffer: Robust Non-Denaturing Protein Extraction
2026-08-01
APExBIO's NP-40 Lysis Buffer stands out as a non-denaturing solution enabling high-yield, native protein extraction from diverse biological sources. Its gentle yet effective lysis supports complex neuroimmunology workflows, including co-immunoprecipitation and phosphoprotein analysis, crucial for dissecting cell signaling in disease models.
Cl-Amidine trifluoroacetate salt: Advanced PAD4 Inhibition i
2026-07-31
Explore the unique translational power of Cl-Amidine trifluoroacetate salt as a PAD4 inhibitor for dissecting immune and epigenetic mechanisms in cancer and sepsis. This article delivers a deep, evidence-based analysis of its applications, mechanistic selectivity, and best-practice protocols.
Deep Learning of USC Mitochondrial Morphology for AD Detecti
2026-07-31
This study pioneers a deep learning framework to analyze mitochondrial morphology in urine-derived stem cells as a non-invasive biomarker for Alzheimer’s disease. The approach demonstrates robust discrimination of mitochondrial alterations linked to cognitive impairment, offering new potential for early AD detection and minimally invasive monitoring.
BMS 309403 and the CaN/FoxO1/FABP4 Axis: Breakthroughs in Ca
2026-07-30
Explore how BMS 309403, a potent FABP4 inhibitor, uniquely enables advanced investigation of the CaN/FoxO1/FABP4 pathway in atherosclerosis and metabolic disease. This article delivers deep mechanistic insights and practical assay guidance beyond standard workflows.
WZ4003: A Selective NUAK1/2 Inhibitor for Cell Migration and
2026-07-30
WZ4003 enables precise inhibition of NUAK1/2 kinases, empowering researchers to dissect cell migration, proliferation, and tau phosphorylation with high specificity. Its robust performance in both cancer biology and neurodegeneration models sets it apart as a versatile chemical probe for translational studies.
ECL Chemiluminescent Substrate Detection Kit: Omics-Ready Pr
2026-07-29
Explore the ECL Chemiluminescent Substrate Detection Kit for advanced Western blot chemiluminescence detection, integrating omics analysis and mechanistic insight. This article uniquely bridges molecular assay optimization with cutting-edge systems biology findings.
Pharmacokinetics of CSBTA in MASH: Impact of Disease State o
2026-07-29
This study systematically dissects how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in a high-fat, high-cholesterol diet mouse model. Findings provide mechanistic insight into the modulation of drug metabolizing enzymes and transporters, underpinning the need for tailored dosing strategies in MASH treatment.
GDC-0941: Precision PI3K Inhibition in Cancer Stem Cell Rese
2026-07-28
Explore the unique potential of GDC-0941 as a PI3K inhibitor targeting cancer stem cell-driven drug resistance. This in-depth analysis reveals new perspectives for translational oncology beyond standard proliferation assays.
ECL Chemiluminescent Substrate Detection Kit: Precision in W
2026-07-28
The ECL Chemiluminescent Substrate Detection Kit by APExBIO delivers robust, ultrasensitive HRP-based detection for both protein and nucleic acid targets. Its optimized luminol-based reaction supports reproducible results, even in challenging Western blot and chemiluminescent immunoassay workflows.
BKT140 (BL-8040): CXCR4 Antagonist for Precision Oncology
2026-07-27
BKT140 (BL-8040) is a potent, orally bioavailable CXCR4 antagonist that inhibits tumor cell migration and supports hematopoietic stem cell mobilization. Its high solubility and purity enable precise application in oncology research workflows. The compound's efficacy and pharmacokinetics are supported by preclinical and clinical evidence.
466 records 10/32 page Previous Next First page 上5页 678910 下5页 Last page